Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Colorcon
Dow
Moodys
McKesson

Last Updated: February 7, 2023

CLINICAL TRIALS PROFILE FOR ABSTRAL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Abstral

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01158820 ↗ Alternative Sedation During Bronchoscopy Completed Hospira, Inc. Phase 4 2010-06-01 This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
NCT01158820 ↗ Alternative Sedation During Bronchoscopy Completed Hospira, now a wholly owned subsidiary of Pfizer Phase 4 2010-06-01 This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
NCT01158820 ↗ Alternative Sedation During Bronchoscopy Completed University of Pennsylvania Phase 4 2010-06-01 This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Abstral

Condition Name

Condition Name for Abstral
Intervention Trials
Pain 2
Acute Pain Due to Trauma 2
Colonoscopy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Abstral
Intervention Trials
Wounds and Injuries 2
Acute Pain 2
Pain, Procedural 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Abstral

Trials by Country

Trials by Country for Abstral
Location Trials
United States 19
Italy 2
Sweden 1
Finland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Abstral
Location Trials
Pennsylvania 2
Texas 2
California 1
Colorado 1
Connecticut 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Abstral

Clinical Trial Phase

Clinical Trial Phase for Abstral
Clinical Trial Phase Trials
Phase 4 5
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Abstral
Clinical Trial Phase Trials
Completed 5
Recruiting 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Abstral

Sponsor Name

Sponsor Name for Abstral
Sponsor Trials
Azienda Sanitaria dell'Alto Adige 2
Hospira, Inc. 1
Hospira, now a wholly owned subsidiary of Pfizer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Abstral
Sponsor Trials
Other 6
Industry 4
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Dow
Moodys
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.